ESTERASE SENSITIVE MOTIF Trademark

Trademark Overview


On Tuesday, May 9, 2017, a trademark application was filed for ESTERASE SENSITIVE MOTIF with the United States Patent and Trademark Office. The USPTO has given the ESTERASE SENSITIVE MOTIF trademark a serial number of 79211487. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, May 22, 2019. This trademark is owned by MACROPHAGE PHARMA LIMITED. The ESTERASE SENSITIVE MOTIF trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Chemicals for use in pharmaceuticals in the nature of chemical preparations for pharmaceutical purposes, namely, for use in oncology, immunotherapy, immuno-oncology and in treating metabolic disease; pharmaceutical preparations for treating cancers; pharmaceutical preparations for use in immuno-oncology; pharmaceutical preparations for use in immunotherapy; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating metabolic disease

Pharmaceutical research and development services; scientific research services; information, advisory and consultancy services relating to the aforesaid
esterase sensitive motif

General Information


Serial Number79211487
Word MarkESTERASE SENSITIVE MOTIF
Filing DateTuesday, May 9, 2017
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, May 22, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesChemicals for use in pharmaceuticals in the nature of chemical preparations for pharmaceutical purposes, namely, for use in oncology, immunotherapy, immuno-oncology and in treating metabolic disease; pharmaceutical preparations for treating cancers; pharmaceutical preparations for use in immuno-oncology; pharmaceutical preparations for use in immunotherapy; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating metabolic disease
Goods and ServicesPharmaceutical research and development services; scientific research services; information, advisory and consultancy services relating to the aforesaid

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, July 8, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, July 8, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMACROPHAGE PHARMA LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Saturday, December 4, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, June 12, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, May 22, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, May 22, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, October 25, 2019NEW REPRESENTATIVE AT IB RECEIVED
Thursday, May 23, 2019ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, May 22, 2019ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, December 28, 2018NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, December 12, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 12, 2018NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, October 23, 2018NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Tuesday, October 23, 2018SUBSEQUENT FINAL EMAILED
Tuesday, October 23, 2018SUBSEQUENT FINAL REFUSAL WRITTEN
Tuesday, September 18, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 17, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 17, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Saturday, May 12, 2018REFUSAL PROCESSED BY IB
Friday, March 16, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, March 16, 2018FINAL REFUSAL E-MAILED
Friday, March 16, 2018FINAL REFUSAL WRITTEN
Thursday, February 8, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 7, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 7, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 1, 2017REFUSAL PROCESSED BY IB
Wednesday, August 16, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, August 16, 2017REFUSAL PROCESSED BY MPU
Tuesday, August 15, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, August 14, 2017NON-FINAL ACTION WRITTEN
Saturday, August 5, 2017ASSIGNED TO EXAMINER
Wednesday, July 12, 2017APPLICATION FILING RECEIPT MAILED
Saturday, July 8, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 6, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB